Enhanced SARS-CoV-2 IgG durability following COVID-19 mRNA booster vaccination and comparison of BNT162b2 with mRNA-1273
SM Ailsworth, B Keshavarz, NE Richards… - Annals of Allergy …, 2023 - Elsevier
Abstract Background BNT162b2 (Pfizer/BioNTech, Comirnaty) and mRNA-1273 (Moderna,
Spikevax) are messenger RNA (mRNA) vaccines that elicit antibodies against the severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike receptor-binding domain (S-
RBD) and have been approved by the US Food and Drug Administration to combat the
coronavirus disease 2019 (COVID-19) pandemic. Because vaccine efficacy and antibody
levels waned over time after the 2-shot primary series, the US Food and Drug Administration …
Spikevax) are messenger RNA (mRNA) vaccines that elicit antibodies against the severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike receptor-binding domain (S-
RBD) and have been approved by the US Food and Drug Administration to combat the
coronavirus disease 2019 (COVID-19) pandemic. Because vaccine efficacy and antibody
levels waned over time after the 2-shot primary series, the US Food and Drug Administration …